Hogan Lovells 2024 Election Impact and Congressional Outlook Report
Drew D. Cook
Counsel Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Drew Cook helps clients handle a broad range of corporate, transactional, and commercial matters, including mergers and acquisitions, equity and debt financings, joint ventures and complex commercial agreements.
Drew focuses his practice on mergers and acquisitions and venture capital transactions. He regularly represents investment funds, corporate strategic investors and emerging and growth-stage companies in financings, acquisitions and divestments, and general corporate and commercial matters. He also advises later-stage and public companies, universities, non-profit hospitals and academic health systems, particularly with respect to investment, acquisition, joint venture, licensing and partnering transactions.
In addition to advising on transactional matters, Drew provides corporate governance and commercial contracting advice to public and private companies. He has experience advising clients in a wide range of industries, including in the defense, government services, health care and life sciences, automotive, and technology sectors.
While in law school, Drew was a member of the Harvard Business Law Review and a summer associate at Hogan Lovells.
Representative experience
Represented Paladin Capital in multiple venture capital investments.
Represented Gilead Sciences and Kite Pharma in multiple venture capital investments.
Represented Avidea Technologies in its acquisition by Vaccitech PLC.
Represented American Institutes for Research in the sale of its Assessment Division to Cambium Learning and in its acquisitions of Impaq, LLC and Kimetrica LLC.
Represented NutriSense, Inc. in its US$25m Series A financing.
Represented Lockheed Martin in connection with strategic investment transaction.
Represented Albert Einstein Healthcare Network in its combination with Thomas Jefferson University.
Represented Bart & Associates, LLC in its private equity investment from Battle Investment Group.
Represented the Albright Stonebridge Group in its private-equity backed acquisition by Dentons Global Advisors.
Represented TRATON SE, a subsidiary of Volkswagen, on its strategic equity investment in TuSimple, a leading developer of autonomous trucks and related technology.
Represented CereVasc, Inc. in its US$43.9m Series A financing, prior equity and debt financings and general corporate matters.
Represented Vanderbilt University in spinoff of Vanderbilt University Medical Center.
Represented Google in multiple venture capital investments.
Represented Chase Pharmaceuticals Corporation in its sale to Allergan plc for US$125m in upfront payments and additional potential milestone payments.
Represented Gemalto N.V. in its acquisition of SafeNet, Inc., a worldwide leader in data protection and software monetization, for US$890m.
Represented GE Healthcare in its acquisition of Thermo Fisher's cell culture, gene modulation, and magnetic beads businesses for US$1bn.
Credentials
Education
- J.D., Harvard Law School, cum laude, 2013
- B.S., University of Virginia, with distinction, 2010
Bar admissions and qualifications
- District of Columbia
- New York
News
Press releases
04 January 2024
Press releases
21 December 2021